Advertisement

Topics

Biotech Stocks Rise After Trump's Drug Price Risk Seems to Lessen

17:13 EDT 21 Jun 2017 | Topix

President Donald Trump once said the drug industry was "getting away with murder," but Wall Street is betting that pharmaceutical companies could end up getting a relatively easy pass as the administration tackles rising drug prices. In the past week, news outlets have reported that an executive order the Trump administration is preparing will contain industry-friendly policies instead of more aggressive proposals.

Original Article: Biotech Stocks Rise After Trump's Drug Price Risk Seems to Lessen

NEXT ARTICLE

More From BioPortfolio on "Biotech Stocks Rise After Trump's Drug Price Risk Seems to Lessen"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...